Cargando…

Combination of Silibinin and Curcumin Reduced Leptin Receptor Expression in MCF-7 Human Breast Cancer Cell Line

BACKGROUND: Leptin and leptin receptor (Ob-R) are associated with worse prognosis, distant metastasis, and poor survival of breast cancer. We investigated the cytotoxic effect of silibinin and curcumin, individually and combined, on Ob-R expression in MCF-7 cells. METHODS: This study was performed f...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalimi-Asl, Somaye, Babaahmadi-Rezaei, Hossein, Mohammadzadeh, Ghorban
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shiraz University of Medical Sciences 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7707627/
https://www.ncbi.nlm.nih.gov/pubmed/33281265
http://dx.doi.org/10.30476/ijms.2019.81934
_version_ 1783617391215771648
author Dalimi-Asl, Somaye
Babaahmadi-Rezaei, Hossein
Mohammadzadeh, Ghorban
author_facet Dalimi-Asl, Somaye
Babaahmadi-Rezaei, Hossein
Mohammadzadeh, Ghorban
author_sort Dalimi-Asl, Somaye
collection PubMed
description BACKGROUND: Leptin and leptin receptor (Ob-R) are associated with worse prognosis, distant metastasis, and poor survival of breast cancer. We investigated the cytotoxic effect of silibinin and curcumin, individually and combined, on Ob-R expression in MCF-7 cells. METHODS: This study was performed from October 2017 to April 2018 at the Department of Clinical Biochemistry, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. The cytotoxic effect of silibinin and curcumin, individually and combined, and their corresponding half-maximal inhibitory concentration (IC(50)) values were determined using the methylthiazolyldiphenyl-tetrazolium bromide (MTT) assay. The cells were treated with different concentrations of silibinin (50-400 μM), curcumin (10-35 μM), and their combinations for 24 and 48 hours. The expression of Ob-R was measured using the Western blot analysis by treating the cells with different concentrations of curcumin (10-25 μM), silibinin (50-250 μM), and their respective combinations. The difference in mean cell viability between the groups was calculated using one-way ANOVA followed by Tukey’s post hoc test. RESULTS: Silibinin and curcumin exerted time- and dose-dependent cytotoxic effect on MCF-7 cells. After treatment with silibinin, the IC(50) values were about 250 and 50 μM at 24 and 48 hours, respectively. In terms of treatment with curcumin, the IC(50) values were about 25 and 15 μM at 24 and 48 hours, respectively. Following treatment with silibinin, the Western blot analysis showed that Ob-R expression significantly decreased at 150 μM (P=0.031) and 200 μM (P=0.023) concentrations. Curcumin did not significantly decrease the Ob-R expression, however, the expression significantly decreased (P=0.004) when it was combined with silibinin. CONCLUSION: The combination of silibinin and curcumin significantly reduced Ob-R expression in MCF-7 cells compared with their individual effects.
format Online
Article
Text
id pubmed-7707627
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Shiraz University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-77076272020-12-05 Combination of Silibinin and Curcumin Reduced Leptin Receptor Expression in MCF-7 Human Breast Cancer Cell Line Dalimi-Asl, Somaye Babaahmadi-Rezaei, Hossein Mohammadzadeh, Ghorban Iran J Med Sci Original Article BACKGROUND: Leptin and leptin receptor (Ob-R) are associated with worse prognosis, distant metastasis, and poor survival of breast cancer. We investigated the cytotoxic effect of silibinin and curcumin, individually and combined, on Ob-R expression in MCF-7 cells. METHODS: This study was performed from October 2017 to April 2018 at the Department of Clinical Biochemistry, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. The cytotoxic effect of silibinin and curcumin, individually and combined, and their corresponding half-maximal inhibitory concentration (IC(50)) values were determined using the methylthiazolyldiphenyl-tetrazolium bromide (MTT) assay. The cells were treated with different concentrations of silibinin (50-400 μM), curcumin (10-35 μM), and their combinations for 24 and 48 hours. The expression of Ob-R was measured using the Western blot analysis by treating the cells with different concentrations of curcumin (10-25 μM), silibinin (50-250 μM), and their respective combinations. The difference in mean cell viability between the groups was calculated using one-way ANOVA followed by Tukey’s post hoc test. RESULTS: Silibinin and curcumin exerted time- and dose-dependent cytotoxic effect on MCF-7 cells. After treatment with silibinin, the IC(50) values were about 250 and 50 μM at 24 and 48 hours, respectively. In terms of treatment with curcumin, the IC(50) values were about 25 and 15 μM at 24 and 48 hours, respectively. Following treatment with silibinin, the Western blot analysis showed that Ob-R expression significantly decreased at 150 μM (P=0.031) and 200 μM (P=0.023) concentrations. Curcumin did not significantly decrease the Ob-R expression, however, the expression significantly decreased (P=0.004) when it was combined with silibinin. CONCLUSION: The combination of silibinin and curcumin significantly reduced Ob-R expression in MCF-7 cells compared with their individual effects. Shiraz University of Medical Sciences 2020-11 /pmc/articles/PMC7707627/ /pubmed/33281265 http://dx.doi.org/10.30476/ijms.2019.81934 Text en Copyright: © Iranian Journal of Medical Sciences http://creativecommons.org/licenses/by-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 4.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Dalimi-Asl, Somaye
Babaahmadi-Rezaei, Hossein
Mohammadzadeh, Ghorban
Combination of Silibinin and Curcumin Reduced Leptin Receptor Expression in MCF-7 Human Breast Cancer Cell Line
title Combination of Silibinin and Curcumin Reduced Leptin Receptor Expression in MCF-7 Human Breast Cancer Cell Line
title_full Combination of Silibinin and Curcumin Reduced Leptin Receptor Expression in MCF-7 Human Breast Cancer Cell Line
title_fullStr Combination of Silibinin and Curcumin Reduced Leptin Receptor Expression in MCF-7 Human Breast Cancer Cell Line
title_full_unstemmed Combination of Silibinin and Curcumin Reduced Leptin Receptor Expression in MCF-7 Human Breast Cancer Cell Line
title_short Combination of Silibinin and Curcumin Reduced Leptin Receptor Expression in MCF-7 Human Breast Cancer Cell Line
title_sort combination of silibinin and curcumin reduced leptin receptor expression in mcf-7 human breast cancer cell line
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7707627/
https://www.ncbi.nlm.nih.gov/pubmed/33281265
http://dx.doi.org/10.30476/ijms.2019.81934
work_keys_str_mv AT dalimiaslsomaye combinationofsilibininandcurcuminreducedleptinreceptorexpressioninmcf7humanbreastcancercellline
AT babaahmadirezaeihossein combinationofsilibininandcurcuminreducedleptinreceptorexpressioninmcf7humanbreastcancercellline
AT mohammadzadehghorban combinationofsilibininandcurcuminreducedleptinreceptorexpressioninmcf7humanbreastcancercellline